IR Summary

Progen Pharmaceuticals Limited is a publicly listed Australian company. Our listing is on the Australian Securities Exchange (ASX) and the US OTC Market (OTC).
Progen has operations in Australia and the US.

Key Statistics
Ownership: Public
Exchanges: ASX and US OTC Market
Ticker Symbols: ASX: PGL; OTC:PGLA
Exchange Listing Dates: ASX: 1995 OTC:2010

Our Vision
Progen’s vision is two-fold: to improve cancer patients’ lives by providing them with improved oncology solutions; and to create long-term shareholder value through the discovery and development of novel cancer therapeutics.

Investment Highlights
  • Novel anti-cancer portfolio spanning drug discovery and development
  • Strong proprietary position through issued/issuing patents
  • Strong management
  • Strong cash position 
  • Deep discovery and preclinical pipeline